Novo Nordisk (NVO) and Viatris (VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo ...

Christine Zhou started her career as a physician and clocked nearly two decades at drugmaker Eli Lilly before joining rival Novo Nordisk in 2018, where she is now president for the China region. China ...

A new study shows semaglutide medications, such as Ozempic and Wegovy, may be effective in treating hidradenitis suppurativa ...

Novo Nordisk and Viatris have agreed to resolve a patent dispute over Novo's blockbuster weight-loss drugs Ozempic and Wegovy ...

In a major milestone the obesity rate dropped by roughly 2% between 2020 and 2023 according to the national health and ...

There’s a lot to think about when you're pregnant or trying to get pregnant. If you take Ozempic®, you’ll need to talk with ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...

A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The State Health Plan's decision to end coverage of certain weight-loss prescription drugs has produced an unlikely and ...

A weight loss and diabetes drug remains in a shortage but for the last month, San Ysidro Pharmacy has been supplying patients ...